Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times Cambodia.
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on July 29, 2025
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
July 29, 2025
SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane …
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
GlobeNewswire
·
July 29, 2025
MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire
·
July 29, 2025
SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday, Aug. 5, 2025. The …
LifeMD to Report Second Quarter 2025 Financial Results on August 5
GlobeNewswire
·
July 29, 2025
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. …
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
GlobeNewswire
·
July 29, 2025
IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, …
Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
GlobeNewswire
·
July 29, 2025
- Appointed Dr. Roger Sidhu as Chief Medical Officer - - Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) - - Announced …
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
GlobeNewswire
·
July 29, 2025
IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2025 and raised its …
Larimar Therapeutics Announces Proposed Underwritten Public Offering
GlobeNewswire
·
July 29, 2025
BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an …
Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints
GlobeNewswire
·
July 29, 2025
- Primary Endpoint Analysis Confirms Favorable Tolerability Profile of ATI-2138 Without Certain Risks Associated with Other Agents in the Class - - Efficacy Results Show Comparable Outcomes to Approved Therapies with Potential for Improved Tolerability, …
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
GlobeNewswire
·
July 29, 2025
Cash and cash equivalents at €122.1 million and €24.6 million in short-term deposits2 as of June 30, 2025 Revenues of €4.5 million recorded in H1 2025 Daix (France), New York City (New York, United States), July 29, 2025 – Inventiva (Euronext Paris and …
Inventiva publie ses informations financières préliminaires du premier semestre 2025¹
GlobeNewswire
·
July 29, 2025
Trésorerie et équivalents de trésorerie de 122,1 millions d’euros et 24,6 millions d’euros de dépôts à court terme2 au 30 juin 2025 Chiffre d’affaires de 4,5 millions d’euros au premier semestre 2025 Daix (France), New York City (New York, Etats-Unis), le …
Grupo Bimbo Commits to Removing All Artificial Colorants by End of 2026
GlobeNewswire
·
July 29, 2025
MEXICO CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Grupo Bimbo, S.A.B. de C.V. (“Grupo Bimbo” or the “Company”) (BMV: BIMBO) is proud to announce its firm commitment to eliminate all artificial colorants from its entire product portfolio by the end of 2026. …
Hematologist Dissatisfaction with Current Warm Autoimmune Hemolytic Anemia (w-AIHA) Treatment Spurs Interest in Late-Stage Pipeline, According to Spherix Global Insights
GlobeNewswire
·
July 29, 2025
EXTON, PA, July 29, 2025 (GLOBE NEWSWIRE) -- According to new findings from Spherix Global Insights’ syndicated Market Dynamix™ service, hematologists managing patients with warm autoimmune hemolytic anemia (w-AIHA) continue to face clinical complexity, a …
Belly Fat Burner: Why Men and Women are Using Strong Over the Counter Diet Supplements like PhenQ to Lose Stubborn Abdominal Fat
GlobeNewswire
·
July 29, 2025
New York City, NY, July 29, 2025 (GLOBE NEWSWIRE) -- In 2025, PhenQ is setting a new standard for belly fat burners with its research-driven, natural solution, providing powerful, long-lasting support for a slimmer, healthier stomach without injections or …
Colonoscopes: Global Markets Surge as Colorectal Cancer Screening Takes Center Stage
GlobeNewswire
·
July 29, 2025
Boston, July 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Colonoscopes: Global Markets” is projected to reach $3.4 billion by the end of 2030, growing at a CAGR of 5.4% during the forecast period from 2025 to 2030. This …
LifeLabs Deepens Support to Communities Impacted by Saskatchewan Wildfires with an Additional $5,000 Donation
GlobeNewswire
·
July 29, 2025
Toronto, ON, July 29, 2025 (GLOBE NEWSWIRE) -- As wildfires continue to impact communities across Saskatchewan, LifeLabs is pleased to deepen its commitment to relief efforts, contributing an additional $5,000. This latest contribution brings the company’s …
Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight
GlobeNewswire
·
July 29, 2025
New York, USA, July 29, 2025 (GLOBE NEWSWIRE) -- Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight The adrenocortical carcinoma market in the 7MM is anticipated to boost during the …
Hapbee Launches Integrated Affiliate and Ambassador Program to Accelerate Growth and Community Expansion
GlobeNewswire
·
July 29, 2025
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTC: HAPBF), the digital wellness company helping users feel better without ingesting substances, proudly announces the official launch of its technology …
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9%
GlobeNewswire
·
July 29, 2025
Consolidated net revenue of € 1,323.8 million in the first half of 2025, +11.7% or +7.8% on a like-for-like basis(3) and at constant exchange rates (CER) EBITDA(1) of € 496.3 million, +9.6%, margin on revenue of 37.5% Adjusted net income(2) of € …
IHA’s Symphony Goes Live as Provider Directory Data Source for Covered California
GlobeNewswire
·
July 29, 2025
OAKLAND, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) announced that its Symphony Provider Directory is now powering Covered California’s online provider directory, helping to ensure that information on providers is …